AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $243K and bought $25K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$218K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 1- Open
- $1.11
- 52-wk high
- $3.70
- High
- $1.13
- 52-wk low
- $1.02
- Low
- $1.06
- Prev close
- $1.11
- Mkt cap
- $243.6M
- Volume
- 1.40M
- Fwd P/E
- 55.9x
- Beta
- 1.09
- P/S
- 1.9x
- P/B
- 2.0x
- Profit margin
- +0.0%
- Op margin
- -4.7%
- ROE
- +2.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about BLND filings
Are insiders buying or selling Blend Labs Inc (BLND) stock?
Net selling: insiders sold $243K and bought $25K of BLND stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. $243K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Venkatramani, Srinivasan (Head of Product Tech & Cust Op), who sold $107K. The latest filing was on Sep 30, 2026.
Which members of Congress have traded BLND recently?
None. No member of Congress disclosed a BLND trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this BLND smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What insiders are doing
How top traders are positioned
No tracked top-trader positions in BLND right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in $0.01 a share below what analysts expected.
Earnings per share
-$0.01 expected
Reports Nov 5, 2026, in 35 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $32.9M | $32.4M | $30.8M | $33.8M |
| Cost of what it sold | $8.4M | $8.0M | $7.5M | $9.0M |
| Gross profit | $24.5M | $24.4M | $23.4M | $24.9M |
| What it spent | ||||
| Research and development | $8.5M | $9.5M | $9.4M | $8.7M |
| Sales and admin | $12.9M | $12.4M | $12.2M | $11.0M |
| Other operating costs | $8.0M | $7.1M | $6.2M | $6.7M |
| Total operating expenses | $29.4M | $28.9M | $27.8M | $26.5M |
| What was left | ||||
| Operating profit | -$4.9M | -$4.5M | -$4.4M | -$1.6M |
| Interest on debt | $0 | $0 | — | — |
| Profit before tax | $12.4M | -$3.1M | -$5.4M | -$1.4M |
| Tax | $27.0K | $151.0K | $63.0K | $119.0K |
| Net profit | $12.5M | -$3.5M | -$8.0M | -$1.5M |
| EBITDA | $12.5M | -$1.7M | -$3.5M | -$1.4M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace